Tredje AP-fonden’s Jazz Pharmaceuticals JAZZ Stock Holding History

Tredje AP-fonden’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-626	Closed	-$118K	–	502
2026 Q1	$118K	Sell	626 -42,574	-99%	-$7.44M	﹤0.01%	545
2025 Q4	$7.34M	Buy	+43,200	New	+$6.62M	0.06%	167
2024 Q2	–	Sell	-9,496	Closed	-$1.14M	–	492
2024 Q1	$1.14M	Hold	9,496	–	–	0.01%	456
2023 Q4	$1.17M	Sell	9,496 -1,095	-10%	-$137K	0.01%	477
2023 Q3	$1.37M	Sell	10,591 -993	-9%	-$132K	0.02%	437
2023 Q2	$1.44M	Sell	11,584 -1,768	-13%	-$238K	0.02%	446
2023 Q1	$1.95M	Buy	13,352 +681	+5%	+$101K	0.03%	391
2022 Q4	$2.02M	Buy	12,671 +373	+3%	+$54.7K	0.03%	367
2022 Q3	$1.64M	Buy	+12,298	New	+$1.87M	0.03%	381
2018 Q2	–	Sell	-9,980	Closed	-$1.51M	–	474
2018 Q1	$1.51M	Buy	9,980 +3,600	+56%	+$528K	0.05%	352
2017 Q4	$859K	Buy	6,380 +3,240	+103%	+$449K	0.03%	447
2017 Q3	$459K	Sell	3,140 -110	-3%	-$16.6K	0.02%	508
2017 Q2	$505K	Buy	3,250 +860	+36%	+$132K	0.02%	506
2017 Q1	$347K	Sell	2,390 -123	-5%	-$16K	0.01%	517
2016 Q4	$274K	Buy	2,513 +893	+55%	+$99.5K	0.01%	516
2016 Q3	$197K	Buy	1,620 +900	+125%	+$121K	0.01%	536
2016 Q2	$102K	Buy	+720	New	+$106K	﹤0.01%	536

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Tredje AP-fonden's JAZZ Position: Q2 2026 in Review

Tredje AP-fonden sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2026, closing a stake of 626 shares — an estimated $118K sold.

Tredje AP-fonden first reported a position in JAZZ in Q2 2016 and held it in 17 quarters. The position peaked at $7.34M in Q4 2025. 641 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Tredje AP-fonden reported no remaining Jazz Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Tredje AP-fonden sold 626 Jazz Pharmaceuticals shares in Q2 2026, an estimated $118K.
Tredje AP-fonden first reported a position in Jazz Pharmaceuticals in Q2 2016 and held it in 17 quarters.
Tredje AP-fonden's Jazz Pharmaceuticals position peaked at $7.34M in Q4 2025.
641 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Tredje AP-fonden's 13F filing for Q2 2026, filed 10 Aug 2026.